Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

INTRODUCTION: Cerebrospinal fluid α-synuclein level is increased in sporadic Creutzfeldt-Jakob disease cases. However, the clinical value of this biomarker remains to be established. In this study, we have addressed the clinical validation parameters and the interlaboratory reproducibility by using...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Kruse, Niels, Heslegrave, Amanda, Gupta, Vandana, Foiani, Martha, Villar-Piqué, Anna, Schmitz, Matthias, Lehmann, Sylvain, Teunissen, Charlotte, Blennow, Kaj, Zetterberg, Henrik, Mollenhauer, Brit, Zerr, Inga, Llorens, Franc
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
CSF Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171371/
https://ncbi.nlm.nih.gov/pubmed/30294658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.06.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars